Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has submitted its financial results for the quarter and nine months ended December 31, 2025 to the NSE. This is a routine regulatory disclosure required of all listed companies. The actual numbers (revenue, profit, margins) were not included in the headline announcement text provided, so specific financial performance details cannot be confirmed from this filing alone. Investors should refer to the full results document for detailed figures.
This is a procedural filing and is neutral for the stock in the short term. Shareholders should review the actual results (revenue, EBITDA, PAT, margins, and management commentary) to assess underlying business performance.